Objectives: This study aimed to combine in vitro phenotyping analysis and whole-genome-
sequencing (WGS) to characterise the phenotype and genetic determinants associated with …

Background Acinetobacter baumannii ability to develop and acquire resistance makes it one
of the most critical nosocomial pathogens globally. Whole-genome sequencing (WGS) was …

Multidrug-resistant (MDR) Acinetobacter baumannii infections are of particular concern
within medical treatment facilities, yet the gene assemblages that give rise to this phenotype …

Introduction: The aim of this study was to investigate the drug-resistance and the molecular
characterization of carbapenemases, ESBL, and aminoglycoside-modifying enzymes …

Carbapenem-resistant Acinetobacter baumannii (A. baumannii, CRAb) is an emerging
global threat for healthcare systems, particularly in Southeast Asia. Next-generation …

Carbapenem resistant Acinetobacter baumannii is a major global concern, especially in
countries of the Middle East and North Africa, where the antibiotic resistance rates are on the …

This study determined the antibiotic susceptibility profile and genetic mechanisms of β-
lactam resistance in 27 clinical strains of Acinetobacter baumannii isolated at the University …

Acinetobacter baumannii is one of the most important opportunistic challenging pathogens
as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety …

Acinetobacter baumannii has emerged as a problematic multidrug-resistant (MDR)
pathogen worldwide. The aim of this study was to characterize clinical isolates of A …

Abstract Background The prevalence of Acinetobacter baumannii in nosocomial infections
and its remarkable ability to develop antimicrobial resistance have been a critical issue in …